ISSCR News


New Podcast Episode. A Look Into the Future of Stem Cell Reports: A Conversation with Janet Rossant
Announcements Megan Koch Announcements Megan Koch

New Podcast Episode. A Look Into the Future of Stem Cell Reports: A Conversation with Janet Rossant

In this special edition of the podcast, we will talk with the new Editor-in-Chief Janet Rossant and hear about her vision for the journal, its promising future, and what she sees as some of the exciting prospects over the horizon for stem cell research. We will also talk with Yvonne Fisher, the journal’s Managing Editor, and Jack Mosher of the ISSCR, about the evolution of the journal and its role in the Society.

Read More
Researchers Develop Personalized Stem Cell Model ALS for Fast, Individualized Drug Testing
Press Release Kym Kilbourne Press Release Kym Kilbourne

Researchers Develop Personalized Stem Cell Model ALS for Fast, Individualized Drug Testing

In amyotrophic lateral sclerosis (ALS), motor neurons that are required for muscle contractions die off, leading to progressive paralysis affecting most muscles of the body. The molecular causes of ALS are poorly understood, and effective treatments are missing.  

To study ALS in the lab, Hideyuki Okano and his colleagues from Keio University, Japan, developed a new method to make motor neurons from stem cells taken directly from ALS patients. The results were just published in the journal Stem Cell Reports.

Read More
New Podcast Episode. SeqVerify: A New Easily Accessible Tool for Comprehensive Cell Line Quality Assessment
Announcements Megan Koch Announcements Megan Koch

New Podcast Episode. SeqVerify: A New Easily Accessible Tool for Comprehensive Cell Line Quality Assessment

During the last decade, advances in genome editing and pluripotent stem cell (PSC) culture have let researchers generate edited PSC lines to study a wide variety of biological questions. However, abnormalities in cell lines such as aneuploidy, mutations, on-target and off-target editing errors, and microbial contamination can arise during PSC culture or due to undesired editing outcomes. To ensure valid experimental results and the safety of PSC-derived therapeutics, it is important to detect these abnormalities and choose PSC lines without them. Existing quality control methods typically focus on detecting one type of abnormality. Whole genome sequencing is an all-in-one detection method for any abnormality involving changes to DNA sequences but until now it has required considerable computational expertise. Today’s guests will discuss a new computational tool, SeqVerify, that analyzes short-read WGS data for quality control of wild-type or edited PSCs. The platform provides an end-to-end analysis framework that can be a valuable quality control method for researchers working with PSCs, and more broadly, for cell line quality control in general.

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .